Filter
558
Filtered Results: 558
Text search:
pharmacovigilance
Featured
Recommendations
61
New Publications
170
Language
Document type
No document type
272
Guidelines
113
Studies & Reports
75
Strategic & Response Plan
29
Manuals
26
Fact sheets
16
Resource Platforms
8
Training Material
7
Situation Updates
5
Online Courses
4
Infographics
2
Videos
1
Countries / Regions
Kenya
26
Congo, Democratic Republic of
17
South Africa
17
Ghana
16
India
16
Nigeria
15
Global
14
Western and Central Europe
14
Uganda
14
Rwanda
12
Senegal
12
Eastern Europe
12
Ethiopia
12
Nepal
10
Latin America and the Carribbean
10
Namibia
10
Africa
9
West and Central Africa
9
Sierra Leone
8
Burkina Faso
8
Malawi
8
Tanzania
8
East and Southern Africa
8
Zambia
8
Madagascar
8
Benin
6
Haiti
6
South–East Asia Region
6
Philippines
5
Cambodia
5
Bangladesh
5
Russia
5
Botswana
5
Liberia
5
Middle East and North Africa
4
Ukraine
3
Lesotho
3
Zimbabwe
3
Mozambique
3
Eastern Europe and Central Asia
3
Chile
2
Cameroon
2
Syria
2
Morocco
2
Asia
2
Paraguay
2
Lebanon
2
Brazil
2
Sudan
2
Chad
2
Libya
2
Indonesia
2
Myanmar / Burma
2
Eswatini/ Swaziland
2
Pakistan
2
Thailand
1
Gambia
1
Laos
1
Afghanistan
1
Burundi
1
Guinea
1
Jordan
1
Western Pacific Region
1
France
1
Maldives
1
Southern Africa
1
Argentina
1
Sri Lanka
1
Yemen
1
Georgia
1
Mali
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Drugs & Medical Equipment
95
Policies
73
Policies & Guidelines HIV & TB
53
Guidelines
50
Studies & Reports
29
COVID-19
19
TB
14
Women & Child Health
12
Capacity Building
11
Statistics
9
NTDs & Others
9
Malaria
9
Disease Prevention & Control
8
HIV & STI
7
Communicable Diseases
5
Pharmacy & Technology
5
Community Health
5
Other
5
Laboratory Quality Assurance
5
Vaccine-preventable Diseases
4
Countries
4
Non-communicable Diseases
4
Hepatitis
3
Online Courses & Platforms
3
Snakebites
3
Leishmaniasis
3
Helminthiasis
2
Taeniasis/ Cysticercosis
2
Public Health
2
Pediatrics
2
Pharmaceutical Assessments
2
NCD
2
Cardiovascular Diseases
2
Medical Devices & Equipment
2
Clinical Guidelines
2
Yellow Fever
2
Immunization
2
General Guidelines
2
Communicable Diseases
2
Gynaecology & Obstetrics
2
Leprosy
2
Maternal Health
2
Pharmacy & Technologies
2
Digital Health
1
Paediatrics
1
Clinical Training
1
Rabies
1
Under-5 nutrition
1
Disaster Preparedness
1
Trachoma
1
Onchocerciasis
1
Schistosomiasis
1
Dermatology
1
Lymphaticfilariasis
1
Humanitarian Aid
1
Cancer
1
General Guidelines
1
Vector Control
1
Monitoring & Evaluation
1
Community Health
1
Pharmacy
1
Pediatric cancer
1
MPOX - Monkeypox
1
Non-communicable Diseases NCD
1
Demograhic Health Surveys DHS
1
Information, Education and Communication (IEC)
1
Respiratory Infections
1
Health Systems
1
Primary Health Care
1
Dengue
1
Key Resources
1
Reproductive Health
1
Global Health
1
Toolboxes
Rational use of Medicine
27
Country specific
22
Pharmacovigilance
20
Drug resistant TB
15
Immunization Guidelines
13
Access & Strategy
12
Pharmacy Practice
11
Clinical Guidelines
10
General Guidelines for Rational Use
9
Falsified & Substandard
8
Reports & Studies
8
Antiretroviral Treatment ART
7
International
6
Country specific documents
6
Hospital Readiness/Essential Health Services
6
Essential Medicines
6
Quality Assurance
6
Traditional & Herbal Medicines
6
Clinical Aspects, Treatment & Prevention
5
Biontech/Pfizer Comirnaty
5
Essential Medicines & Devices Lists
5
Prevention & Preparedness
4
Supporting tools
4
General
4
Country Specific
4
Vaxzevria (Astra Zeneca)
4
Inactivated COVID-19 Vaccines
4
Overview, Studies & Reports
4
Research & Access
4
Eastern Europe & Central Asia
4
SEAR (South-east Asia Region)
4
Agriculture & Veterinary
3
Treatment & Prevention
3
Adults
3
Children
3
Essential Medicines & Medical Devices
3
Moderna
3
Research & Pipeline
3
Online Courses
3
Western & Central Europe
3
Surveillance
2
Yellow Fever
2
Clinical Aspects
2
Preparedness, Response & Risk Communication
2
Prevention & Control
2
Children & Adolescents
2
Ukraine
2
WPRO (Western Pacific Region)
2
Namibia
2
Research
2
Georgia
2
Drug resistance
2
Ethiopia
2
Studies
2
Health Personnel
2
Context & Facts, Travel Advice
2
Online Courses & Resources
2
Infection Control General
2
Country-specific Platforms
2
Oxygen Therapy
2
Logistics & Supply
2
Fair Allocation & Ethical Aspects
2
Prices and Patents
2
Pharmacy Management
2
Pharmaceutical Assessments
2
One Health
2
Waste Managment
2
Resource Platforms
2
Studies & Reports
2
Patient Safety
2
Co-Morbidities (except TB)
2
Education of students & professionals
2
Training
2
Uganda
2
HIV service delivery
2
Kenya
2
Country Specific Information
2
Reports & Studies
2
Eastern Europe and central Asia
2
Outbreak Prevention & Control
1
Clinical Guidelines
1
Surveillance
1
Childhood TB
1
Clinical Guidelines
1
Azerbaijan
1
Vaccines & Immunization
1
Vaccination
1
South Africa
1
Opportunistic Infections
1
Influenza
1
Treatment Guidelines HIV
1
Public Health
1
Surveillance
1
HIV
1
Prevention & Control
1
Rwanda
1
Vaccination
1
TB & Other Vulnerable Populations
1
Country Guidelines
1
Belarus
1
Laboratory & Sampling
1
Reports
1
Russia
1
DR Congo
1
COVID-19
1
Surveillance & Contact tracing
1
For Pregnant Women
1
Training, others
1
Clinical Guidelines
1
Appeals and Response Plans
1
Gender Aspects
1
Videos
1
Vaccine Candidates & Research
1
Communication Material
1
TB/HIV
1
COVAX Initiative
1
mRna Vaccines general
1
Vector-based Vacines General
1
Johnson & Johnson
1
Sputnik V
1
Standard Operating Procedure (SOP)
1
Sanitation
1
Others
1
Online Courses
1
Midwives
1
Booster Doses
1
Model Formulary
1
Supply Chain & Store Management
1
General documents One Health
1
Guidelines & Manuals
1
Antimicrobial Resistance (AMR)
1
Non-communicable Diseases NCD
1
WASH Water Sanitation & Hygiene
1
Heat
1
General
1
Waste management
1
MPOX - Monkeypox
1
Leishmaniasis
1
Strategies & Roadmaps
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Statistics & Facts
1
Studies & Reports
1
Studies & Reports
1
Clinical Aspects & Diagnosis
1
Clinical Aspects & Diagnosis
1
Prevention & Strategies
1
Clinical Aspects & Diagnosis
1
Diagnosis
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Romania
1
Asia and Pacific
1
Neurological Disorders
1
General Aspects
1
Regional Reports & Guidelines, others
1
Human Rights & the Right to Health
1
TB & Prisoners
1
Roadmaps, Action Plans & Policies
1
General Public
1
TB/HIV Coinfection
1
Clinical Guidelines
1
Kazakhstan
1
AmR (Region of Americas)
1
TB
1
Reports & Studies Children HIV
1
Meningitis & Encephalitis
1
Universal Health Coverage & Primary Health Care
1
Preparedness & Prevention
1
Treatment & Clinical Management
1
Interim guidance. 12 May 2021. The Continuity of essential health services: Facility Assessment Tool can be used by countries to rapidly assess the capacity of health facilities to maintain the provision of essential health services during the COVID-19 pandemic. It can help to alert the authorities ...
Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to ident...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public health guiding principles in the human health sect...
Module appartenant à la série d’évaluations des capacités des services de santé dans le cadre de la pandémie de COVID-19: orientations provisoires, 12 mai 2021. L'outil d'évaluation de la continuité des services de santé essentiels : Facility Assessment Tool peut être utilisé par les pa...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to...
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE...
module de la série d’évaluation des capacités des services de santé dans le contexte de la pandémie de COVID-19, 7 juillet 2021
This is a guidance document for countries and implementing partners on the technical requirements for developing digital information systems for issuing standards-based interoperable digital certificates for COVID-19 vaccination status, and considerations for implementation of such systems, for the ...
Orientations provisoires 19 juillet 2021
interim guidance, 19 July 2021 (arabic version)
his Framework begins with a desired future scenario and considers actions and interventions necessary to get there. It advocates for holistic view to address tuberculosis. The Framework revisits challenges and actions in four layers: TB specific; challenges in health systems that influence TB care; ...
Tuberculosis continues to represent a severe public health problem in the Region of the Americas, even more so in the case of indigenous peoples, whose TB incidence is much higher than that of the general population. To achieve tuberculosis control in these communities, it is necessary to respond t...
